At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,389 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
PASCOE-Agil HOM-Injektopas in the Treatment of Rheumatic Disorders: A Non-interventional Observational Study.
In Brief
An observational study for Rheumatic Diseases and 3 related conditions. Completed, enrolled 1,389 participants.
Detailed Summary
The purpose of this observational study is to give an overview of the use of PASCOE-Agil HOM-Injektopas in a 2-4 week treatment of rheumatic disorders.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsRheumatic Diseases, Arthralgia, Myalgias/Myopathy, Lumbago
Countries--
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2009
Primary CompletionMay 2009
First PostedJun 2009
TodayJul 2026
First PostedJun 17, 2009
Enrollment StartJan 1, 2009
Primary CompletionMay 1, 2009
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 17.0 years ago